These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28083598)

  • 1. [Drug treatment of dementia].
    Kraft JW
    Internist (Berl); 2017 Feb; 58(2):117-124. PubMed ID: 28083598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antidementia drugs].
    Müller-Spahn F; Sollberger D; Wollmer MA
    Ther Umsch; 2009 Jun; 66(6):432-40. PubMed ID: 19496039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cholesterol inhibitor and memantine in symptomatic dementia therapy].
    Rodda J; Carter J
    Praxis (Bern 1994); 2013 Feb; 102(5):293-300; discussion 298-9. PubMed ID: 23446240
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of Alzheimer disease.
    Winslow BT; Onysko MK; Stob CM; Hazlewood KA
    Am Fam Physician; 2011 Jun; 83(12):1403-12. PubMed ID: 21671540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current antidementive therapy].
    Perneczky R; Kurz A
    MMW Fortschr Med; 2004 May; 146 Spec No 2():53-6. PubMed ID: 15376702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Consensus statement "Dementia 2010" of the Austrian Alzheimer Society].
    Schmidt R; Marksteiner M; Dal-Bianco P; Ransmayr G; Bancher C; Benke T; Wancata J; Fischer P; Leblhuber CF; Psota G; Ackerl M; Alf C; Berek K; Croy A; Delazer M; Fasching P; Frühwald T; Fruhwürth G; Fuchs-Nieder B; Gatterer G; Grossmann J; Hinterhuber H; Iglseder B; Imarhiagbe D; Jagsch C; Jellinger K; Kalousek M; Kapeller P; Ladurner G; Lampl C; Lechner A; Lingg A; Nakajima T; Rainer M; Reisecker F; Spatt J; Walch T; Uranüs M; Walter A
    Neuropsychiatr; 2010; 24(2):67-87. PubMed ID: 20605003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs for cognitive loss and dementia.
    Treat Guidel Med Lett; 2010 Mar; 8(91):19-24. PubMed ID: 20179667
    [No Abstract]   [Full Text] [Related]  

  • 8. When should drug treatment be started for people with dementia?
    Singh B; O'Brien JT
    Maturitas; 2009 Mar; 62(3):230-4. PubMed ID: 19201114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Starting Alzheimer therapy in early stages whenever possible. Activities of daily living remain intact longer].
    Fuchsberger T; Padberg F; Faltraco F; Möller HJ; Hampel H
    MMW Fortschr Med; 2002 May; 144(20):36-9. PubMed ID: 12119881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability of memantine in combination with cholinesterase inhibitors in dementia therapy.
    Hartmann S; Möbius HJ
    Int Clin Psychopharmacol; 2003 Mar; 18(2):81-5. PubMed ID: 12598818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of memantine for the treatment of dementia.
    Lo D; Grossberg GT
    Expert Rev Neurother; 2011 Oct; 11(10):1359-70. PubMed ID: 21955192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Depression in Patients with Dementia: Is Pharmacological Treatment Justified?
    Ford AH; Almeida OP
    Drugs Aging; 2017 Feb; 34(2):89-95. PubMed ID: 28074409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memantine for dementia?
    Drug Ther Bull; 2003 Oct; 41(10):73-6. PubMed ID: 14593973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The agony and (rational) alternative. Recommendations of the drug commission on antidementia agents].
    Dietmaier O
    Pharm Unserer Zeit; 2002; 31(4):394-400. PubMed ID: 12162070
    [No Abstract]   [Full Text] [Related]  

  • 15. Weight-loss associated with anti-dementia drugs in a patient with Parkinson's disease.
    Gallini A; Sommet A; Salandini AM; Veyssière P; Montastruc JL; Montastruc JL
    Mov Disord; 2007 Oct; 22(13):1980-1. PubMed ID: 17657810
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined Memantine and Donepezil Treatment Improves Behavioral and Psychological Symptoms of Dementia-Like Behaviors in Olfactory Bulbectomized Mice.
    Yabuki Y; Matsuo K; Hirano K; Shinoda Y; Moriguchi S; Fukunaga K
    Pharmacology; 2017; 99(3-4):160-171. PubMed ID: 28049192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.
    Masterman D
    Clin Geriatr Med; 2004 Feb; 20(1):59-68. PubMed ID: 15062487
    [No Abstract]   [Full Text] [Related]  

  • 18. Memantine: pharmacological properties and clinical uses.
    Kumar S
    Neurol India; 2004 Sep; 52(3):307-9. PubMed ID: 15472417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACP Journal Club. Review: cholinesterase inhibitors but not memantine increase syncope in older adults with mild cognitive impairment or dementia.
    Ng B
    Ann Intern Med; 2011 Nov; 155(10):JC5-10. PubMed ID: 22084357
    [No Abstract]   [Full Text] [Related]  

  • 20. Memantine for treatment of moderate to severe Alzheimer's disease.
    Perras C
    Issues Emerg Health Technol; 2005 Mar; (64):1-4. PubMed ID: 15762015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.